Evaluation of Outcomes From Treatment of Benign or Malignant Pancreatic Diseases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMethodist Health System
About this trial
This study will be a retrospective chart review of patients who have been diagnosed with the benign or malignant pancreatic disease under the practice of Dr. Rohan Jeyarajah, M.D., Dr. Houssam Osman M.D., and Dr. Edward Cho M.D., Sc.M. at Methodist Health System Hospital in Richardson, Texas(TX). The investigators plan to conduct an analysis of patients meeting the inclusion criteria from 2005 to present. Study will also be conducted by the PI, Sub-Is, surgery fellows, office staff and clinical research coordinator who are delegated to do by the PI. Data will be obtained by looking through either investigator's patients or through a national database. Data will be analyzed primarily by the study conductors.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
• All patients diagnosed and treated for pancreatic diseases, benign or malignant from 2005 to present
Age ≥18 years
Disqualifiers
• Patients that are not diagnosed with or treated for pancreatic diseases
Age < 18 years
Trial population
All past patients who were treated for a particular benign or malignant pancreatic disease process under evaluation from 2005 to present will be included in this study.
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Overall survival
Number of patients who have been diagnosed with benign or malignant pancreatic disease
Time frame
2005 to 2019Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov